Nordea Investment Management’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-142,200
Closed -$3.73M 1061
2017
Q2
$3.73M Buy
142,200
+1,300
+0.9% +$32K 0.01% 450
2017
Q1
$3.3M Buy
140,900
+27,100
+24% +$669K 0.01% 476
2016
Q4
$2.86M Buy
113,800
+48,900
+75% +$1.23M 0.01% 462
2016
Q3
$1.82M Buy
64,900
+2,700
+4% +$69.2K ﹤0.01% 498
2016
Q2
$1.53M Sell
62,200
-800
-1% -$19.9K ﹤0.01% 469
2016
Q1
$1.39M Buy
63,000
+2,400
+4% +$63.9K ﹤0.01% 486
2015
Q4
$2.12M Sell
60,600
-500
-0.8% -$15.7K 0.01% 380
2015
Q3
$1.74M Sell
61,100
-9,400
-13% -$316K 0.01% 347
2015
Q2
$2.35M Buy
70,500
+2,400
+4% +$73.7K 0.01% 302
2015
Q1
$1.92M Buy
+68,100
New +$1.69M 0.01% 341

Other funds holding PMC

Nordea Investment Management's PMC Position: Q3 2017 in Review

Nordea Investment Management sold out of PharMerica Corporation (PMC) in Q3 2017, closing a stake of 142,200 shares — an estimated $3.73M sold.

Nordea Investment Management first reported a position in PMC in Q1 2015 and held it in 10 quarters. The position peaked at $3.73M in Q2 2017. 150 funds tracked by Wall St. Rank hold PMC as of Q3 2017.

  • Nordea Investment Management reported no remaining PharMerica Corporation position as of Q3 2017 after selling out during the quarter.
  • Nordea Investment Management sold 142,200 PharMerica Corporation shares in Q3 2017, an estimated $3.73M.
  • Nordea Investment Management first reported a position in PharMerica Corporation in Q1 2015 and held it in 10 quarters.
  • Nordea Investment Management's PharMerica Corporation position peaked at $3.73M in Q2 2017.
  • 150 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2017.

Based on Nordea Investment Management's 13F filing for Q3 2017, filed 9 Nov 2017.